Shah , D and Challagundla, N and Dave, V and Patidar, A and Saha, B and Nivsarkar , M and Trivedi, VB and Agrawal-Rajput, R (2022) Berberine mediates tumor cell death by skewing tumor-associated immunosuppressive macrophages to inflammatory macrophages. Phytomedicine. 2021 Dec 22;99:153904. Phytomedicine, 99. p. 153904.
Full text not available from this repository. (Request a copy)Abstract
Background: Berberine is a plant-derived alkaloid with potent anti-cancer activities. Berberine may redirect the tumor-promoting immunosuppressive M2 macrophages, to tumoricidal activated M1 macrophages. But such an anti-tumor function remains to be demonstrated. Hypothesis: Polarization of macrophages to an immunosuppressive phenotype within the tumor microenvironment promotes tumor growth and contributes to resistance to chemotherapy. We examined if berberine would target macrophage polarization to reinstate anti-tumor immune response. Study design: Using a B16F10 mouse melanoma model, we assessed berberine-induced re-polarization of immunosuppressive M2 macrophages to anti-tumor M1 macrophages and subsequent T-cell activation within the immunosuppressive tumor microenvironment. Methods: The B16F10 culture supernatant along with tumor antigen was used as tumor mimicking conditioned medium (CM). The bone marrow-derived macrophages were cultured in CM for 5 days. The CM-induced skewing of macrophages to M2-like phenotype was confirmed by flow cytometry and ELISA. The T-cells were co-cultured with macrophages to decipher the effect of berberine on T-cell differentiation. In vivo efficacy of berberine was analyzed using melanoma model of solid tumor.
Item Type: | Article |
---|---|
Subjects: | Infection and Immunity |
Depositing User: | Mr. Rameshwar Nema |
Date Deposited: | 12 Oct 2022 06:59 |
Last Modified: | 12 Oct 2022 06:59 |
URI: | http://nccs.sciencecentral.in/id/eprint/1145 |
Actions (login required)
View Item |